A newer and longer-acting form of the diabetes drug exenatide (Byetta) taken once a week did better at controlling blood glucose levels compared to its standard formula, according to a new study published recently in the journal, The Lancet.

» Continue Reading

Related terms:

• diabetes once a week shot
• glucose control shot
• name of once a week shot for diabetes
• once a week blood sugar controll shots
• once a week diabetic shot
• once a week glucose control injection
• once a week glucose shot
• once a week injection for blood sugar control
• shot once a week
• sugar control shot

EIi Lilly and Company and Amylin Pharmaceuticals, Inc. recently announced that the European Commission has granted marketing authorization for Byetta (exenatide) for the treatment of type 2 diabetes. Exenatide is now approved in the European Union as adjunctive therapy to improve blood sugar control in patients with type 2 diabetes who have not achieved adequate glycemic control on maximally tolerated doses of metformin and/or a sulfonylurea, two common oral diabetes medications. Exenatide is the first in a new class of antidiabetic medicines known as incretin mimetics.

» Continue Reading

The use of insulin pens is fast becoming a norm among diabetic patients for its convenience. Insulin pen offers portability which means it can be carried easily anywhere and conveniently be injected anywhere and anytime. It extinguishes the fear of using needles especially among children. Insulin pen allows diabetics to administer insulin discretely. It has a longer shelf life and more importantly, it allows for administering accurate dosage of insulin.

» Continue Reading